Patents by Inventor Michael K. Hoskins

Michael K. Hoskins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL PREPARATION FOR TREATING HUMAN SKIN
    Publication number: 20210259964
    Abstract: An antiviral preparation for treating skin includes an alpha hydroxy acid and a source of chlorine dioxide in a waterless ointment base. This antiviral preparation can be manufactured at a low cost, and is very effective in treating topical viral infections, such as cold sores, warts, genital herpes, shingles, and molluscum contagiosum. The antiviral preparation substantially reduces the healing time for cold sores. In addition, one formulation of the antiviral preparation is suitable as a pour-on treatment for burns.
    Type: Application
    Filed: February 25, 2020
    Publication date: August 26, 2021
    Inventor: Michael K. Hoskins
  • ANTIVIRAL PREPARATION FOR TREATING HUMAN SKIN
    Publication number: 20210259965
    Abstract: An antiviral preparation for treating skin includes an alpha hydroxy acid and a source of chlorine dioxide in a waterless ointment base. This antiviral preparation can be manufactured at a low cost, and is very effective in treating topical viral infections, such as cold sores, warts, genital herpes, shingles, and molluscum contagiosum. The antiviral preparation substantially reduces the healing time for cold sores. In addition, one formulation of the antiviral preparation is suitable as a pour-on treatment for burns.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 26, 2021
    Inventor: Michael K. Hoskins
  • Stabilized isoenzyme control products
    Patent number: 4883762
    Abstract: Isoenzyme control reagents and methods for making same stabilized by means of plexiform stabilizing means. The preferred plexiform stabilizing means is selected from the group consisting of monosaccharide and disaccharide reducing sugars. The most preferred isoenzyme control reagent comprises the isoenzyme of interest obtained from selected tissue, preclarified human sera, stabilizing cofactor, a chelating agent means, a weak nonphospate buffer and lactose as the most preferred plexiform stabilizing means.
    Type: Grant
    Filed: January 12, 1989
    Date of Patent: November 28, 1989
    Assignee: Ciba Corning Diagnostics Corp.
    Inventor: Michael K. Hoskins
  • Stabilized isoenzyme control products
    Patent number: 4684615
    Abstract: Isoenzyme control reagents and methods for making same stabilized by means of plexiform stabilizing means. The preferred plexiform stabilizing means is selected from the group consisting of monosaccharide and disaccharide reducing sugars. The most preferred isoenzyme control reagent comprises the isoenzyme of interest obtained from selected tissue, preclarified human sera, stabilizing cofactor, a chelating agent means, a weak nonphosphate buffer and lactose as the most preferred plexiform stabilizing means.
    Type: Grant
    Filed: September 29, 1986
    Date of Patent: August 4, 1987
    Assignee: Ciba Corning Diagnostics Corp.
    Inventor: Michael K. Hoskins
  • Liquid clinical control standard, and reagent products
    Patent number: 4678754
    Abstract: This invention relates to the field of clinical controls useful for calibrating clinical chemistry analyzers and in manual testing methods, as well as clinical standards and reagents. In addition, it relates to methods for producing stabilized liquid clinical control, standards, and reagents.
    Type: Grant
    Filed: November 3, 1986
    Date of Patent: July 7, 1987
    Assignee: Ciba Corning Corp.
    Inventor: Michael K. Hoskins
  • Estrogen-progesterone control reagents and methods for making same
    Patent number: 4663295
    Abstract: Reagents useful for steroid receptor assays containing both progesterone and estrogen receptors and methods. The reagents of the instant invention contain both estrogen and progesterone receptors in a stabilized format. A preferred embodiment includes target tissue material obtained from calf uteri having the required receptors, HEPES suspending buffer, a binding site activation inhibitor, dithiothreotol, plexiform stabilizing matrix means and an amount of inactive protein added as necessary to meet predetermined total protein levels.
    Type: Grant
    Filed: June 29, 1983
    Date of Patent: May 5, 1987
    Assignee: Ciba Corning Diagnostics Corp.
    Inventors: Martha Vail, Robert E. Megraw, Michael K. Hoskins
  • Liquid clinical control, standard, and reagent products
    Patent number: 4643976
    Abstract: This invention relates to the field of clinical controls useful for calibrating clinical chemistry analyzers and in manual testing methods, as well as clinical standards and reagents. In addition, it relates to methods for producing stabilized liquid clinical control, standards, and reagents.
    Type: Grant
    Filed: June 3, 1985
    Date of Patent: February 17, 1987
    Assignee: Ciba Corning Diagnostics Corp.
    Inventor: Michael K. Hoskins
  • Blood gas controls composition, method and apparatus
    Patent number: 4289648
    Abstract: A hermetically sealed ampoule containing blood gas control fluid is provided wherein the fluid occupies the entire ampoule with no appreciable head space. The ampoule is provided with a plunger-like seal adapted to be directed against the contents of the ampoule and a pierceable seal through which may extend a hollow needle to act as a conduit for the contents upon expulsion from the ampoule. A syringe is also provided for expelling the contents from the ampoule.
    Type: Grant
    Filed: March 20, 1979
    Date of Patent: September 15, 1981
    Assignee: Ortho Diagnostics, Inc.
    Inventors: Michael K. Hoskins, Gary D. Christiansen